-+ 0.00%
-+ 0.00%
-+ 0.00%

NewGenIVF to buy additional 3% stake in K25.ai at US$250 million valuation

PUBT·07/27/2026 12:31:39
Listen to the news
NewGenIVF to buy additional 3% stake in K25.ai at US$250 million valuation
  • NewGenIVF entered a definitive agreement to buy an additional 3% of K25.ai at a USD 250 million equity valuation.
  • Transaction value set at USD 7.5 million; aggregate stake expected to rise to 13% from 10% on completion.
  • Consideration includes issuance of about 2,500,000 Class A ordinary shares; total shares expected to increase to about 5,900,000.
  • New share issuance expected to lift market capitalization above USD 5 million, supporting Nasdaq listing compliance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270830PRIMZONEFULLFEED9798454) on July 27, 2026, and is solely responsible for the information contained therein.